Massoumi R - Search Results

1

CYLD: a deubiquitination enzyme with multiple roles in cancer.

Massoumi R. Massoumi R. Future Oncol. 2011 Feb;7(2):285-97. doi: 10.2217/fon.10.187. Future Oncol. 2011. PMID: 21345146 Review.

2

Tetraploidization Increases the Motility and Invasiveness of Cancer Cells.

Jemaà M, Daams R, Charfi S, Mertens F, Huber SM, Massoumi R. Jemaà M, et al. Among authors: massoumi r. Int J Mol Sci. 2023 Sep 10;24(18):13926. doi: 10.3390/ijms241813926. Int J Mol Sci. 2023. PMID: 37762227 Free PMC article.

3

Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth control.

Massoumi R, Paus R. Massoumi R, et al. Bioessays. 2007 Dec;29(12):1203-14. doi: 10.1002/bies.20677. Bioessays. 2007. PMID: 18008375 Review.

4

Ubiquitin chain cleavage: CYLD at work.

Massoumi R. Massoumi R. Trends Biochem Sci. 2010 Jul;35(7):392-9. doi: 10.1016/j.tibs.2010.02.007. Epub 2010 Mar 26. Trends Biochem Sci. 2010. PMID: 20347313 Review.

5

Serum response factor controls CYLD expression via MAPK signaling pathway.

Liang G, Ahlqvist K, Pannem R, Posern G, Massoumi R. Liang G, et al. Among authors: massoumi r. PLoS One. 2011 May 5;6(5):e19613. doi: 10.1371/journal.pone.0019613. PLoS One. 2011. PMID: 21573132 Free PMC article.

6

GLI1-dependent transcriptional repression of CYLD in basal cell carcinoma.

Kuphal S, Shaw-Hallgren G, Eberl M, Karrer S, Aberger F, Bosserhoff AK, Massoumi R. Kuphal S, et al. Among authors: massoumi r. Oncogene. 2011 Nov 3;30(44):4523-30. doi: 10.1038/onc.2011.163. Epub 2011 May 16. Oncogene. 2011. PMID: 21577203

7

Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer.

Masoumi KC, Shaw-Hallgren G, Massoumi R. Masoumi KC, et al. Among authors: massoumi r. J Skin Cancer. 2011;2011:614097. doi: 10.1155/2011/614097. Epub 2011 Dec 17. J Skin Cancer. 2011. PMID: 22235375 Free PMC article.

8

CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.

Pannem RR, Dorn C, Ahlqvist K, Bosserhoff AK, Hellerbrand C, Massoumi R. Pannem RR, et al. Among authors: massoumi r. Carcinogenesis. 2014 Feb;35(2):461-8. doi: 10.1093/carcin/bgt335. Epub 2013 Oct 8. Carcinogenesis. 2014. PMID: 24104553

9

Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells.

Kobayashi T, Masoumi KC, Massoumi R. Kobayashi T, et al. Among authors: massoumi r. Oncogene. 2015 Apr 23;34(17):2251-60. doi: 10.1038/onc.2014.159. Epub 2014 Jun 9. Oncogene. 2015. PMID: 24909169

10

Deubiquitination of γ-tubulin by BAP1 prevents chromosome instability in breast cancer cells.

Zarrizi R, Menard JA, Belting M, Massoumi R. Zarrizi R, et al. Among authors: massoumi r. Cancer Res. 2014 Nov 15;74(22):6499-508. doi: 10.1158/0008-5472.CAN-14-0221. Epub 2014 Sep 16. Cancer Res. 2014. PMID: 25228651

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters